Robin Bechhofer
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 15
- Immune Cell Function and Interaction 13
- Immunotherapy and Immune Responses 8
- Immune Response and Inflammation 4
- Toxin Mechanisms and Immunotoxins 2
- Oncology 9
- Cancer Immunotherapy and Biomarkers 7
- Chemokine receptors and signaling 1
- Co-authors
- Barry E. Storer (12 shared papers)Peter Köhler (9 shared papers)Paul M. Sondel (7 shared papers)Jacquelyn A. Hank (9 shared papers)Kate H. Moore (6 shared papers)J A Hank (3 shared papers)Jeff Sosman (4 shared papers)Nancy S. Rosenthal (2 shared papers)
- Journals
- Cancer Investigation (2 papers)Journal of Immunotherapy (2 papers)JNCI Journal of the National Cancer Institute (2 papers)Therapeutic Innovation & Regulatory Science (1 paper)Cancer (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Robin Bechhofer
18 papers receiving 703 citations
Peers
Comparison fields: 5 of 65
- Immunology 463
- Oncology 309
- Neurology 67
- Hematology 37
- Emergency Medicine 27
Countries citing papers authored by Robin Bechhofer
This map shows the geographic impact of Robin Bechhofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Bechhofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Bechhofer more than expected).
Fields of papers citing papers by Robin Bechhofer
This network shows the impact of papers produced by Robin Bechhofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Bechhofer. The network helps show where Robin Bechhofer may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Bechhofer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer. | 1988 | 142 |
| 2 | 1988 | 120 | |
| 3 | 1988 | 88 | |
| 4 | In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2. | 1988 | 70 |
| 5 | Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients. | 1997 | 62 |
| 6 | 2001 | 38 | |
| 7 | 1989 | 31 | |
| 8 | 1990 | 29 | |
| 9 | A direct comparison of immunological and clinical effects of interleukin 2 with and without interferon-alpha in humans. | 1993 | 27 |
| 10 | 1992 | 21 | |
| 11 | Depressed in vitro T cell responses concomitant with augmented interleukin-2 responses by lymphocytes from cancer patients following in vivo treatment with interleukin-2. | 1990 | 21 |
| 12 | Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity. | 1989 | 21 |
| 13 | The in vitro function of lymphocytes from 25 cancer patients receiving four to seven consecutive days of recombinant IL-2. | 1988 | 20 |
| 14 | Clinical and immunological effects of treatment with murine anti-CD3 monoclonal antibody along with interleukin 2 in patients with cancer. | 1995 | 16 |
| 15 | 2017 | 14 | |
| 16 | 1991 | 14 | |
| 17 | 1993 | 9 | |
| 18 | Phase 1 clinical evaluation of recombinant interleukin-2. | 1987 | 7 |
About Robin Bechhofer
Robin Bechhofer is a scholar working on Immunology, Oncology, Pathology and Forensic Medicine, Neurology and Hematology, having authored 18 papers that have together received 750 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Response and Inflammation (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Immunology (463 citations), Oncology (309 citations), Neurology (67 citations), Hematology (37 citations) and Emergency Medicine (27 citations). Robin Bechhofer has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Barry E. Storer, Peter Köhler, Paul M. Sondel, Jacquelyn A. Hank, Kate H. Moore, J A Hank, Jeff Sosman, Nancy S. Rosenthal, Jeffrey A. Sosman and Paul M. Sondel. Their work appears in journals such as Cancer Investigation, Journal of Immunotherapy, JNCI Journal of the National Cancer Institute, Therapeutic Innovation & Regulatory Science and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.